Melanoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years old or older and have been recently diagnosed with breast cancer, colorectal cancer, melanoma, non-Hodgkin lymphoma, or non-small cell lung cancer.
- You are scheduled to receive chemotherapy (one or more drugs, including targeted therapy) and/or a type of immunotherapy called an immune checkpoint inhibitor — you can still join up until the start of your second round of treatment if you couldn't sign up before treatment began.
- You are able to read and understand English or Spanish, as surveys are in these languages.
- You have a working email address and are willing to fill out surveys online, whether at home, in the clinic, or elsewhere.
- You have completed a confidential self-reported screening survey and received a result showing you are eligible.
- You currently live in the United States, as confirmed by your own report on the screening survey.
- Your doctor believes you have a life expectancy of at least 6 months.
Optional sub-study (only available at certain locations):
- You are willing to take part in both the main study and an additional sub-study at Wake Forest University Comprehensive Cancer Center or Virginia Commonwealth University.
- You are receiving your cancer treatment at one of those two specific locations.
- You have been diagnosed with non-small cell lung cancer.
- Your treatment plan includes a chemotherapy drug called paclitaxel along with an immune checkpoint inhibitor.
Who may not be able to join:
- You are currently enrolled in another clinical trial focused on managing cancer symptoms.
- You are currently pregnant.
- You have previously received systemic cancer treatment for a prior cancer, including chemotherapy, immunotherapy, targeted therapy, or hormonal therapy.
- You are currently enrolled in hospice care.
For the optional sub-study only:
- You are regularly taking steroid medications or immune-modifying drugs (such as prednisone, dexamethasone, etanercept, or infliximab) — note that steroids taken as a pre-medication before chemotherapy are allowed (confirm with trial site).
- You have a history of HIV, hepatitis B, or hepatitis C.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Glenn Lesser, MD, Wake Forest University Health Sciences
Phone: 336-716-0891
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Cancer-related symptoms
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.